Literature DB >> 18172091

Analysis of the posterior polymorphous corneal dystrophy 3 gene, TCF8, in late-onset Fuchs endothelial corneal dystrophy.

Jodhbir S Mehta1, Eranga N Vithana, Donald T H Tan, Victor H K Yong, Gary H F Yam, Ricky W K Law, Wesley G W Chong, Calvin P Pang, Tin Aung.   

Abstract

PURPOSE: Because the endothelial (posterior) corneal dystrophies share common pathologic features and result from primary endothelial dysfunction, it is possible that a proportion of them could be clinical manifestations of different mutations of the same gene. The aim of our study was to determine whether mutations of the TCF8 gene, recently implicated in posterior polymorphous dystrophy, may also play a role in the development of the more common Fuchs endothelial corneal dystrophy (FECD).
METHODS: Genomic DNA was extracted from leukocytes of peripheral blood, and the nine exons of the TCF8 gene were PCR amplified and subjected to bidirectional sequencing and analysis. Samples from 74 unrelated Chinese patients (55 women, 19 men) with a diagnosis of late-onset FECD and 93 age- and race-matched controls were studied.
RESULTS: The affected probands ranged in age from 52 to 91 years (mean age, 65.1 years); 8 had familial FECD and 66 had sporadic FECD. The authors found two mutations in the coding region of the TCF8 gene: a novel missense mutation in one patient c.2087A>G in exon 7 (Asn696Ser) and a silent mutation in exon 2 c.192T>C (D64D).
CONCLUSIONS: The identification of a novel missense mutation in only one of the patients implied that TCF8 does not play a significant role in the pathogenesis of FECD in this Chinese population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18172091     DOI: 10.1167/iovs.07-0847

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  45 in total

1.  A single-base substitution in the seed region of miR-184 causes EDICT syndrome.

Authors:  Benjamin W Iliff; S Amer Riazuddin; John D Gottsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

2.  TCF4 Triplet Repeat Expansion and Nuclear RNA Foci in Fuchs' Endothelial Corneal Dystrophy.

Authors:  V Vinod Mootha; Imran Hussain; Khrishen Cunnusamy; Eric Graham; Xin Gong; Sudha Neelam; Chao Xing; Ralf Kittler; W Matthew Petroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-26       Impact factor: 4.799

Review 3.  The Molecular Basis of Fuchs' Endothelial Corneal Dystrophy.

Authors:  Jie Zhang; Charles N J McGhee; Dipika V Patel
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

4.  Fuchs' corneal dystrophy.

Authors:  Allen O Eghrari; John D Gottsch
Journal:  Expert Rev Ophthalmol       Date:  2010-04

5.  Spontaneous corneal clearing after Descemet's stripping without endothelial replacement.

Authors:  Rupa D Shah; J Bradley Randleman; Hans E Grossniklaus
Journal:  Ophthalmology       Date:  2011-10-07       Impact factor: 12.079

6.  Posterior polymorphous corneal dystrophy 3 is associated with agenesis and hypoplasia of the corpus callosum.

Authors:  Michelle S Jang; Ashley N Roldan; Ricardo F Frausto; Anthony J Aldave
Journal:  Vision Res       Date:  2014-04-26       Impact factor: 1.886

7.  The genetics of Fuchs' corneal dystrophy.

Authors:  Benjamin W Iliff; S Amer Riazuddin; John D Gottsch
Journal:  Expert Rev Ophthalmol       Date:  2012-08

8.  Genetic analysis of patients with Fuchs endothelial corneal dystrophy in India.

Authors:  Boomiraj Hemadevi; Muthiah Srinivasan; Jambulingam Arunkumar; Namperumalsamy V Prajna; Periasamy Sundaresan
Journal:  BMC Ophthalmol       Date:  2010-02-10       Impact factor: 2.209

9.  Phenotypic characterisation and ZEB1 mutational analysis in posterior polymorphous corneal dystrophy in a New Zealand population.

Authors:  Andrea L Vincent; Rachael L Niederer; Amanda Richards; Betina Karolyi; Dipika V Patel; Charles N J McGhee
Journal:  Mol Vis       Date:  2009-12-03       Impact factor: 2.367

Review 10.  Corneal dystrophies.

Authors:  Gordon K Klintworth
Journal:  Orphanet J Rare Dis       Date:  2009-02-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.